Hizentra 20% subcutaneous injection 4g/20mL (YJ code: 6343439A3027, 4g 20mL 1 bottle), manufactured by CSL Behring, contains pH4 treated acidic human immunoglobulin (subcutaneous injection). This medication is used for replacement therapy in primary immunodeficiency (PI) and for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) in adults.
Hizentra 20% subcutaneous injection 4g/20mL
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).